Abstract
Thrombus treatment and prevention can be regulated by a number of intravenous or subcutaneous drugs, as well as oral warfarin. Many therapies require laboratory monitoring for efficacy and for detection of dangerous sequelae, such as bleeding, thrombosis, or heparin induced thrombocytopenia.
MeSH terms
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / blood
-
Fibrinolytic Agents / pharmacokinetics
-
Fibrinolytic Agents / pharmacology
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Monitoring, Physiologic
-
Thrombosis / drug therapy
-
Thrombosis / prevention & control
-
United States